Selskabsmeddelelse5.3.2025, 12.30BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North
Selskabsmeddelelse20.2.2025, 19.00BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy
Selskabsmeddelelse17.2.2025, 11.15BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt
Selskabsmeddelelse12.2.2025, 15.00BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy
Selskabsmeddelelse10.2.2025, 07.00BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations
Selskabsmeddelelse6.2.2025, 13.00BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company
Selskabsmeddelelse31.1.2025, 14.30BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors
Selskabsmeddelelse18.12.2024, 12.00Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement
Selskabsmeddelelse18.12.2024, 11.00BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement
Selskabsmeddelelse13.12.2024, 11.00BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025
Selskabsmeddelelse13.12.2024, 07.30BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations
Video2.12.2024, 14.00Life Science Companies as Investments | Life Science Night Dec. 2, 2024Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.
Selskabsmeddelelse29.11.2024, 14.30BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans
Selskabsmeddelelse29.11.2024, 14.20BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Selskabsmeddelelse29.11.2024, 13.00BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company
Selskabsmeddelelse26.11.2024, 15.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Selskabsmeddelelse22.11.2024, 17.05BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
Selskabsmeddelelse22.11.2024, 17.00BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations
Selskabsmeddelelse14.11.2024, 12.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Selskabsmeddelelse7.11.2024, 11.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd